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Reinstatement of Reﬂex Testing of Stool
Samples for Vancomycin-Resistant Enterococci
(VRE) Resulted in Decreased Incidence of
Hospital-Associated VRE
Vancomycin-resistant enterococci (VRE) infections result in
increased hospital costs and lengths of stay.1 Previously, we
described a hospital-wide “reﬂex” testing program for
detecting VRE intestinal colonization as an intervention to
limit nosocomial transmission.2 Inpatients that had diarrheal
stools submitted to the clinical microbiology laboratory for
Clostridium difﬁcile (C. difﬁcile) toxin testing also had
screening cultures for VRE. In July 2010, this program was
discontinued, and in the following 18 months, the monthly
incidence of healthcare-associated VRE increased by 71%.
Based on these ﬁndings, the VRE reﬂex testing program was
reinstated in January 2012. We examined the effect of
reinstatement of the VRE reﬂex testing program on
healthcare-associated VRE incidence.
methods
Barnes-Jewish Hospital is a 1,250-bed academic tertiary care
hospital in Saint Louis, Missouri. We examined the healthcare-
associated VRE rate between January 2009 and December
2015. Reﬂex testing for VRE was discontinued in July 2010 and
was reinstated in January 2012. Clinicians were notiﬁed of
these changes to VRE reﬂex testing. Throughout the study
period, clinicians could order stool or perirectal cultures for
VRE testing at their discretion. The hospital policy during the
study was to place VRE colonized or infected patients on
contact precautions in a private room. During the reﬂex
screening period 1 (January 2009 to July 2010), stool speci-
mens were plated on Enterococcosel Agar (Becton Dickinson,
Sparks, MD). During screening period 2 (January 2012 to
December 2015), chromID VRE (bioMerieux, Durham, NC)
was used. No differences in the screening cultures performed
that were positive for VRE were detected for either screening
period: 2,457 of 9,637 (25.5%) for period 1 versus 6,289 of
24,920 (25.2%) for period 2 (P= .62).
All hospitalized patients with a positive urine or blood
culture for VRE were identiﬁed. A healthcare-associated VRE
case was deﬁned as the ﬁrst positive specimen per patient,
where VRE was detected in blood or urine ≥3 calendar days
after admission. A VRE case was considered present on
admission if VRE was detected in blood or urine <3 calendar
days after admission.3 In the original study, we deﬁned
healthcare-associated VRE as an initial positive culture within
48 hours after admission. The VRE incidence was expressed as
cases per 10,000 patient days.
The effect of reﬂex testing on the incidence of healthcare-
associated VRE was evaluated using regression models with
autoregressive integrated moving average (ARIMA) errors. In
addition to reﬂex testing, VRE prevalence on admission,
central line utilization, urinary catheter utilization, and overall
temporal trend were considered in the model to evaluate the
effects of these factors on healthcare-associated VRE rate
during the study period. The Washington University Human
Research Protection Ofﬁce approved this study.
results
In the initial reﬂex testing period, there were 99 cases of
healthcare-associated VRE; 36 cases (36.4%) were identiﬁed via
blood cultures and 63 cases (63.6%) were identiﬁed via urine
cultures, for an overall rate of 2.3 VRE cases per 10,000 patient
days. During the period when reﬂex testing was discontinued,
there were 166 cases of healthcare-associated VRE; 63 cases
(38.0%) were identiﬁed via blood cultures and 103 cases
(62.0%) were identiﬁed via urine cultures, for an overall rate of
3.7cases per 10,000 patient days. During the study period after
reﬂex testing was reinstated, there were 218 cases of VRE;
57 cases (26.1%) were identiﬁed via blood cultures and 161
cases (73.9%) were identiﬁed via urine cultures, for an overall
rate of 1.8 cases per 10,000 patient days (Figure 1). Accounting
for the overall temporal trend, healthcare-associated VRE
decreased at a rate of 36.4% (−36.4; 95%CI, −50.9 to −17.7) per
month over the entire study period. The average healthcare-
associated VRE rate was 1.9 cases per 10,000 patient days during
the reﬂex testing periods versus 3.7 cases per 10,000 patient
days during the nontesting period. When adjusted for
VRE prevalence on admission and overall temporal trend,
reﬂex testing was associated with a 32.0% reduction (−32.0;
reinstatement of vre reﬂex testing 619
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/ice.2017.19
Downloaded from https:/www.cambridge.org/core. Washington University St. Louis, on 13 May 2017 at 00:26:39, subject to the Cambridge Core terms of use, available at
95% CI, −48.2 to −10.8) in healthcare-associated VRE
incidence compared to the non–reﬂex testing period.
discussion
In this follow-up study, we noted that hospital-wide reinsti-
tution of a VRE reﬂex screening program led to a decrease in
hospital-associated VRE incidence to a baseline rate similar to
pre-discontinuation period, which further suggested a causal
relationship between the program and a reduction in hospital-
associated VRE transmission.4 Most hospitals, often due to the
lack of routine active surveillance, do not identify a large
proportion of colonized patients who are potential sources for
ongoing hospital transmission.5,6 Some studies have demon-
strated the beneﬁt of active surveillance cultures to control
VRE transmission in hospitals; however, these were generally
conducted during an outbreak in which multiple interventions
were introduced simultaneously.7,8 In our previous study, we
found that discontinuation of reﬂex VRE testing of each stool
sample submitted for testing for C. difﬁcile at our hospital
resulted in a 71% increase in the endemic healthcare-
associated VRE rate (Figure 1). This long-term, follow-up
analysis indicated that when reﬂex VRE testing was reimple-
mented, healthcare-associated VRE rates returned to the
prediscontinuation baseline.
Our study has several limitations. Our data were collected
from a single care center and did not include patient-level
characteristics. Another concern is the change in the screening
method of stool specimens. However, the percentage of
positive screening tests did not change signiﬁcantly. The
strengths of our study include repeated treatment design9 and
the use of regression models with ARIMA errors to
appropriately account for correlated observations over time
and to adjust for the overall temporal trend and important
confounders such as VRE prevalence on admission. Further-
more, no other speciﬁc infection prevention measures were
implemented over the study period, and laboratory methods
for identifying VRE from urine and blood cultures did not
change. Also, there were no outbreaks of C. difﬁcile during this
period.
In conclusion, we found that the use of VRE reﬂex testing of
stool submitted for C. difﬁcile testing was effective in reducing
the incidence of hospital-associated VRE infections when
combined with a contact precautions program. This strategy
should be considered a valid method of reducing VRE
transmission in hospital settings.
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Impact of Changes to the National Healthcare
Safety Network (NHSN) Deﬁnition on
Catheter-Associated Urinary Tract Infection
(CAUTI) Rates in Intensive Care Units at an
Academic Medical Center
Catheter-associated urinary tract infections (CAUTIs) account
for >30% of hospital-acquired infections (HAIs) reported by
acute-care hospitals.1,2 Acute-care hospitals are incentivized to
reduce CAUTIs because it is one of the measures included in the
Centers for Medicare and Medicaid (CMS) hospital-acquired
condition reduction program.3 The National Healthcare
Safety Network (NHSN) provides standardized criteria for the
surveillance deﬁnitions for CAUTI. There were major concerns
with the previous 2013 NHSN CAUTI surveillance deﬁnition.4
Effective January 2015, signiﬁcant changes were made to the
NHSN CAUTI deﬁnition: (1) the removal of urinalysis criteria,
(2) an increase in the urine culture bacterial threshold from 103
to 105 colony-forming units (cfu), and (3) the exclusion of
yeasts ormolds as potential CAUTI pathogens.5 The objective of
our study was to determine the impact of the current 2015
NHSN CAUTI deﬁnition on publicly reported CAUTI rates in
intensive care units (ICUs) at our academic medical center.
methods
We performed a retrospective analysis of the prospectively
collected CAUTI surveillance data from January 1, 2013, to
June 30, 2016. The setting included 7 ICUs at the University
of Alabama at Birmingham Hospital, a 1,157-bed academic
medical center. Trained infection preventionists perform
CAUTI surveillance using the applicable NHSN deﬁnition and
calculate the standardized infection ratio (SIR). To decrease
the incidence of CAUTI, a CAUTI prevention bundle was
implemented in late 2013, which included a nurse-driven
urinary catheter removal protocol, an annual mandatory HAI
prevention education module for all healthcare providers, and
training of nursing staff in the proper techniques for urinary
catheter insertion.
We examined the trend of our reported CAUTI rates from
January 2013 to June 2016 in 7 ICUs and applied the current
2015 CAUTI deﬁnition to 2013 and 2014 CAUTI cases. Rates
were compared using Pearson’s χ2 test; means were compared
using 2-sample t test; and P≤ .05 was considered statistically
signiﬁcant. Catheter utilization ratio (CUR, catheter days
divided by patient days) was calculated to determine changes
in the volume of catheter use. Data analyses were performed
using Stata version 12.0 (StataCorp, College Station, TX).
results
When the corresponding NHSN deﬁnition for the respective
year was applied, we observed a trend for decreasing yearly
CAUTI rates. Even before the NHSN deﬁnition was updated, but
during the implementation of the CAUTI prevention bundle, we
observed a signiﬁcant decrease in the CAUTI incidence rate (IR)
from 5.7 UTIs per 1,000 catheter days in 2013 to 3.9 UTIs per
1,000 catheter days in 2014 (P< .001). During the 2-year period
between January 2013 and December 2014, 345 CAUTIs
occurred, but more than half of these did not meet the current
(2015) NHSN deﬁnition. Notably, 44.1% of CAUTIs in 2013
and 50.3% in 2014 were due to yeast (Table 1).
With the current 2015 NHSN deﬁnition, we observed a
signiﬁcant decline in the CAUTI IR in 2015: 0.98 UTIs per
1,000 catheter days in 2015 versus 3.89 in 2014 (P< .001).
When the current 2015 NHSN deﬁnition was applied to the
2013 CAUTI data, the CAUTI IR decreased by 57.5% from 5.7
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